Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients. - Wikidata - wikimedia - TriplyDB

Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients.

Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients.

http://www.wikidata.org/entity/Q35599599

about

Interventions for dialysis patients with hepatitis C virus (HCV) infection Interferon for Hepatitis C Virus in Hemodialysis--an Individual Patient Meta-analysis of Factors Associated with Sustained Virological Response Managing chronic hepatitis C in the difficult-to-treat patient Diagnosis, management, and treatment of hepatitis C: an update Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India.Efficacy and tolerability of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C.Pegylated-interferon alpha 2a treatment for chronic hepatitis C in patients on chronic haemodialysis.Pilot study of pegylated interferon-alpha 2a in dialysis patients with chronic hepatitis C virus infection.Novel assay using total hepatitis C virus (HCV) core antigen quantification for diagnosis of HCV infection in dialysis patients Hepatitis C virus infection and dialysis: 2012 update.Management of hepatitis C virus infection in hemodialysis patients.Management of hepatitis C in patients with chronic kidney disease.Management of the kidney transplant patient with chronic hepatitis C infection Hepatitis C and kidney transplantation Management of patients with hepatitis C infection and renal disease.Hepatitis C in hemodialysis patients Incidence of CMV-HCV coinfection in renal transplant recipient.Recurrent hepatitis C post-transplantation: where are we now and where do we go from here? A report from the Canadian transplant hepatology workshop.Hepatitis C in dialysed patients--what is the current optimal treatment?Hepatitis C in hemodialysis patients: current global magnitude, natural history, diagnostic difficulties, and preventive measures.Efficacy and safety of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C.Treatment of chronic hepatitis C in hemodialysis patients.Superior outcomes in HIV-positive kidney transplant patients compared with HCV-infected or HIV/HCV-coinfected recipients Lack of Efficacy of Pegylated Interferon Monotherapy for Hepatitis C in Patients With End-Stage Renal Disease on Dialysis.Efficacy and tolerability of low-dose interferon-α in hemodialysis patients with chronic hepatitis C virus infection.Treatment of hepatitis C virus infection in patients with end-stage renal disease.Hepatitis C virus infection in end-stage renal disease and kidney transplantation.Hepatitis C virus infection and kidney transplantation in 2014: what's new?Hepatitis C infection and chronic renal diseases.Outcomes of treatment with daclatasvir and asunaprevir for recurrent hepatitis C after liver transplantation.Pharmacokinetics, efficacy and safety of daclatasvir plus asunaprevir in dialysis patients with chronic hepatitis C: pilot study.Effect and Safety of Daclatasvir-Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b -Infected Patients on Hemodialysis.Hepatitis C Virus Infection in Patients with End-Stage Renal Disease: A Study from a Tertiary Care Centre in India.Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis.What are the management issues for hepatitis C in dialysis patients?: management of hepatitis C infection in kidney transplant candidates.What are the management issues for hepatitis C in dialysis patients?: hepatitis C virus infection and its treatment in patients with end-stage renal disease.Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial.A Better Quality of Life in Hemodialysis Patients With Viral Hepatitis: Is it a Reality?Efficacy and tolerance of interferon-alpha in the treatment of chronic hepatitis C in end-stage renal disease patients on hemodialysis.Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients.

P2860

Q24187826-4C84723E-3D5C-4C7E-BC39-708AD6256CB9 Q27489433-8A8E2E27-EB20-418C-BDCA-B71744606F84 Q27490409-AB9EEB52-CC50-4762-BBF1-DD907A11B595 Q29619682-386FD558-3C33-41CE-947D-27B27567BFC9 Q30417045-C3A23F90-C67B-498D-A128-7D6548F027F1 Q33370971-82C5C83E-39F3-4B5A-A3C5-D424CADB1892 Q33371890-59E2C247-2DA1-4AD6-BB0D-A7448D000FFD Q33374217-0F35B9FA-C3F7-4D7C-8448-4EBDD1F51AD2 Q33592762-C6D679F5-4859-45A5-9082-09EF8285502E Q33710828-7F5A5A03-879C-4405-986D-9A1FAEACFB02 Q33845152-FF1810A0-D7CD-42C7-9E48-E6843A86B05D Q34932338-0BCB62F4-1AEF-4778-B291-B3CD1B863E40 Q34988932-E5CE17F3-7964-4862-91C3-42BD53C58AC5 Q35094769-02380D6F-4FFD-4191-92BB-FF078AF9063C Q35127041-3A844837-A3AC-4427-AEAB-1D61258637F1 Q35237329-4B741283-0771-4D1B-8C89-5036F3F4E6C7 Q35919439-62A47846-53A1-4DBD-900E-860C746A7BDE Q36655931-3E4E2058-2640-4402-B3DC-B61ABECDE667 Q36796785-3215AFAB-1C3B-4E22-A6B3-9E4C3DF4077A Q37088857-C01478FD-69A3-4B48-AD83-B01EBBBE5ECF Q37174162-DAC89716-9AAD-4EA6-8824-A70BEEF0E686 Q37313163-2350A994-B05E-4F18-A77A-3C1ABE6ABB62 Q37420014-29430F34-89D8-48D6-98D7-CB62EDAECA53 Q37692546-7E5D1CF0-61AB-40D8-9027-4B5321CB9EDC Q37697588-E0A1E071-D770-4599-B1AC-732B462BB361 Q37831965-9ADF14A3-96F3-4D84-B902-166ACF0453DD Q38213956-BF895C91-4E01-449B-8642-0305BC630F43 Q38236820-D2E60923-FC9B-4463-889C-43E87076BB99 Q38552198-CDE15875-1071-4E85-8887-8116B0DE1B61 Q40400190-6A1B9EE0-9E2C-489F-B871-1A5304AE917D Q40471417-B2D7BB65-9227-4391-80C5-E153D4A9CC8A Q40503590-BC0B9B43-9A71-4243-B83F-00E6368E8CF5 Q40668424-C3BD3396-254C-45A8-87C8-378102C813B3 Q40793177-3F3CF055-EE41-47E6-BE44-D4DF0538AC6E Q41745939-4318AC97-4777-4D44-8F83-1D8F0C800079 Q41745947-8B6A15B8-A24A-4979-9755-9D2C5D57EDA5 Q42223532-6838E171-98B0-4021-A520-749E03995378 Q42248455-CE37EDC5-E376-4439-A7EB-5185E2D0DBAF Q42999273-38100A0F-7AC5-47BB-9DDF-C54754FCC9DF Q42999766-B1733D4F-DF4D-42E8-9247-0D9D2179EC35

P2860

Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients.

http://www.wikidata.org/entity/Q35599599

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients.

@ast

Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients.

@en

type

label

Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients.

@ast

Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients.

@en

prefLabel

Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients.

@ast

Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients.

@en

P1433

Q35599599-5E867D4E-6731-414D-B608-AD18737E835F

P1476

Q35599599-7510F602-C518-43BE-9F58-0A8072DFF1C7

P2093

Q35599599-106B9EE7-8B33-4051-9402-3024124D3561

Q35599599-189C60EE-0142-4147-897E-30F134BF0C05

Q35599599-21DCA245-FF57-4628-8832-71AF70AA4FC3

Q35599599-9BC1C494-3048-4E30-8295-2A08C7FC99BD

Q35599599-F5993346-2C26-408C-879B-D72CE89D4F9D

P2860

Q35599599-01193658-39E9-4721-A16E-791E399BB6F5

Q35599599-0D1152D4-4281-43F7-B5E5-E0CADC845C28

Q35599599-12ED2C7E-C394-4A1F-B724-C7490815F5E7

Q35599599-17B4022B-69A3-41E7-8F6C-432AB27AA5FB

Q35599599-33498F2D-61DB-4C0A-ABBF-86D246D3370C

Q35599599-4FC2E8A8-C1A1-4ADA-9E2A-BC261D691025

Q35599599-502A91D8-EFBB-4EF6-80B7-3E52BE6E6E9A

Q35599599-51C4CAB9-49B6-48F8-B96C-B6F4BD3F66F5

Q35599599-548ED16F-C8A8-420B-9438-344620F66A6B

Q35599599-56B50E11-B21D-443F-90C7-BAD522DC7D22

P304

Q35599599-28967DF5-44E7-4AC0-9469-939037FAEBEC

P31

Q35599599-7cecd386-87a6-4720-9350-c377c2cc5a22

Q35599599-8c530155-bd93-4357-870b-585a0564adc2

Q35599599-9FF867DA-1456-42CB-B3B8-4A52C6DC85BD

P356

Q35599599-AB2F7BD5-2F2D-4CCB-8D4C-4DE4E880C1F8

P407

Q35599599-B502DEB9-3F3F-4F1D-A43D-36C34E653F0A

P433

Q35599599-E9B9779D-7A13-4B7F-906B-333543AC916A

P478

Q35599599-6AA8A122-25F2-4C37-A46D-745C992E157B

P577

Q35599599-82AE49FA-078F-4424-A14F-627C66358B87

P5875

Q35599599-E7A38F14-65D0-43E9-9C64-1CF12B968276

P698

Q35599599-0C22061E-5970-4640-A053-CCAF998ABA07

P921

Q35599599-45929F6A-4663-49E5-A868-2F47E7D9190C

P356

J.1365-2036.2003.01780.X

P1433

Alimentary Pharmacology & Therapeutics

P1476

Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients.

@en

P2093

Bunnapradist S

http://www.w3.org/2001/XMLSchema#string

Dixit V

http://www.w3.org/2001/XMLSchema#string

Dulai G

http://www.w3.org/2001/XMLSchema#string

Fabrizi F

http://www.w3.org/2001/XMLSchema#string

Martin P

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis in clinical trials

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

Cancer in patients on dialysis for end-stage renal disease: an international collaborative study.

Hepatitis C infection and the patient with end-stage renal disease.

Introduction to therapy of hepatitis C.

Hepatitis virus infection in haemodialysis patients from Moldavia.

Effectiveness and tolerance of interferon-alpha 2b in the treatment of chronic hepatitis C in haemodialysis patients.

A double-blind controlled trial of recombinant interferon-alpha 2b in haemodialysis patients with chronic hepatitis C virus infection and abnormal aminotransferase levels. Nephrologists' Group for the Study of HCV infection.

Association of hepatitis C virus infection with mortality and graft survival in kidney-pancreas transplant recipients.

P304

1071-1081

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1365-2036.2003.01780.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

11-12

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2003-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5905471

http://www.w3.org/2001/XMLSchema#string

P698

14653826

http://www.w3.org/2001/XMLSchema#string

P921